BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 31 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $21,882 | -83.3% | 66,309 | -63.5% | 0.00% | – |
| Q4 2022 | $130,927 | -70.0% | 181,843 | -50.1% | 0.00% | – |
| Q3 2022 | $437,000 | +0.7% | 364,720 | 0.0% | 0.00% | – |
| Q2 2022 | $434,000 | -44.9% | 364,720 | 0.0% | 0.00% | – |
| Q1 2022 | $788,000 | +23.1% | 364,720 | -15.2% | 0.00% | – |
| Q4 2021 | $640,000 | -49.0% | 430,078 | 0.0% | 0.00% | – |
| Q3 2021 | $1,256,000 | -10.3% | 430,078 | +1.4% | 0.00% | – |
| Q2 2021 | $1,400,000 | +85.4% | 424,311 | +111.3% | 0.00% | – |
| Q1 2021 | $755,000 | +26.7% | 200,787 | +19.0% | 0.00% | – |
| Q4 2020 | $596,000 | -47.9% | 168,765 | -3.0% | 0.00% | – |
| Q3 2020 | $1,143,000 | -12.8% | 174,003 | -1.3% | 0.00% | – |
| Q2 2020 | $1,311,000 | +47.8% | 176,356 | -6.3% | 0.00% | – |
| Q1 2020 | $887,000 | – | 188,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 159,500 | $563,000 | 0.11% |
| Ikarian Capital, LLC | 500,000 | $1,765,000 | 0.08% |
| Anson Funds Management LP | 99,103 | $350,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 66,558 | $235,000 | 0.04% |
| AJU IB Investment Co., Ltd. | 25,651 | $91,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 53,041 | $187,000 | 0.01% |
| SHUFRO ROSE & CO LLC | 12,941 | $46,000 | 0.00% |
| Baker Brothers Advisors | 249,123 | $879,000 | 0.00% |
| Tekla Capital Management LLC | 6,000 | $21,000 | 0.00% |
| Orion Capital Management LLC | 500 | $2,000 | 0.00% |